Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,267 total articles
Longview Grindr Holdings Limited, controlled by Lu James Fu Bin, sold 1,450,000 shares of Grindr Inc. (NASDAQ: GRND) common stock in three transactions between February 4 and February 6, 2026, generating about $14.6 million. The sales reduced the indirect stake while Longview continues to hold over 18.4 million shares. Separately, Grindr amended an…
Goldberg Chen, CoreWeave's Senior Vice President of Engineering, sold 17,985 Class A shares on Feb. 5, 2026, at a weighted average price of $79.6937 for a total of $1.43 million and exercised options on 37,500 shares the same day. The company has attracted a $2 billion equity investment from NVIDIA and faces divergent analyst price targets as it pr…
CoreWeave director and chief strategy officer Brian M. Venturo, via West Clay Capital LLC, sold 214,954 Class A shares on February 4, 2026, for about $23.9 million and converted Class B shares into 281,250 Class A shares. The transactions leave West Clay Capital holding 11,434,292 Class B shares and no Class A shares. Separately, NVIDIA committed a…
Mitsui Sumitomo Insurance Co., Ltd., a 10% shareholder of W. R. Berkley Corporation (NYSE: WRB), acquired $2.8 million of Berkley common stock across transactions executed on February 5 and 6, 2026, under a Rule 10b5-1 purchase plan adopted October 3, 2025. Following the buys the firm directly holds 56,458,656 shares. InvestingPro data shows WRB tr…
Tether Global-linked investment vehicles and an individual investor acquired $4,220,297 of Rumble Inc. Class A common stock across three transactions between February 3 and February 6, 2026. Following the purchases, Tether Investments, S.A. de C.V. directly holds 105,174,015 shares. Separately, Rumble reported improved quarterly losses, slightly lo…
Robin Tomasello, Chief Accounting Officer at SentinelOne, sold 2,975 Class A shares on February 6, 2026, in a transaction valued at $39,121. The sale was an issuer-mandated 'sell to cover' to satisfy tax withholding for vesting Restricted Stock Units and not a discretionary trade. SentinelOne's shares are trading near a 52-week low and the company …
SentinelOne President and CEO Tomer Weingarten sold 23,063 Class A shares on February 6, 2026, in a transaction required to cover tax withholding related to restricted stock units. The sale netted $303,278 and followed a period in which the company's stock traded near its 52-week low. SentinelOne continues to report strong revenue growth and is pur…
Ha Daisy Y, a director at Hope Bancorp Inc., executed two sales of common stock on February 5 and 6, 2026, disposing of a total 56,553 shares for roughly $708,083, according to a Form 4 filed with the SEC. The transactions occurred shortly after the bank reported fourth-quarter 2025 results that topped Wall Street estimates for both earnings and re…
David M. Carter, president of Kratos Defense & Security Solutions' DRSS division, sold 3,900 shares on February 5, 2026, for a total of $349,593 under a 10b5-1 plan. Post-sale, Carter holds 77,826 shares. The stock trades above its Fair Value estimate, while Kratos continues to make program and capacity strides including selection for the War Depar…
Glen W. Hauenstein, President of Delta Air Lines, sold 13,576 shares on Feb. 5, 2026, for $71.00 per share, totaling $963,896. The move came a day after 741,030 shares vested from Performance Restricted Stock Units, with 330,056 shares withheld to satisfy tax obligations. Delta separately announced a quarterly dividend and a purchase agreement with…
Arlo Technologies' general counsel Brian Busse disposed of 47,329 shares across transactions on February 4 and February 6, 2026, to meet estimated tax withholding connected to the settlement of restricted stock units. The moves coincided with an award of performance stock units that resulted in the issuance of 57,410 shares valued at $0 upon meetin…
Alphabet's CEO Sundar Pichai completed a series of equity transactions in early February 2026, including the sale of 27,300 Class C shares for $10.9 million and additional share movements tied to tax obligations and a zero-cost issuance. The moves occur as Alphabet reports robust Q4 2025 performance and several banks lift price targets amid growth …
Delta Air Lines Executive Vice President and Chief Information Officer Rahul D. Samant disposed of 62,528 shares on Feb. 5, 2026 for roughly $4.38 million, following the vesting of performance-restricted stock units the prior day. The company's recent corporate actions include a quarterly dividend, a confirmed widebody aircraft purchase agreement a…
Ira Liran, a director at The Vita Coco Company, sold 50,000 shares of the company's common stock on February 5, 2026, for roughly $2.8 million across two transactions. The trades occurred under a Rule 10b5-1 plan and coincided with a period of strong share appreciation and several notable corporate and policy developments affecting the company.
East West Bancorp director Molly Campbell sold 1,800 shares on Feb. 6, 2026, for about $221,058, leaving her with 5,756 shares. The disclosure came in a Form 4 filing. Separately, the bank reported fourth-quarter EPS of $2.55 versus a $2.49 consensus and pre-provision net revenue of $490.2 million, prompting Stephens to raise its price target from …
East West Bancorp Executive Vice President Gary Teo sold 7,000 shares on February 6, 2026, for $858,130 at a weighted average price of $122.59. After the transaction Teo retains 5,252 shares directly and holds 436 shares indirectly through a 401(k) plan. The sale coincides with the bank's fourth-quarter 2025 results, which delivered EPS of $2.55 ve…
Axos Financial director James John Court sold 11,163 shares on February 6, 2026, for about $1.13 million in multiple trades. The company reported better-than-expected second-quarter fiscal 2026 results, with EPS of $2.25 and revenue of $385.1 million, and several analysts raised price targets citing robust loan and deposit growth.
David Sponsel, Executive Vice President of Sales at Alphatec Holdings Inc (NASDAQ: ATEC), sold 60,425 shares on February 5, 2026, for $833,260 under a 10b5-1 trading plan. The transaction occurred at a weighted average price of $13.79, within a $13.43 to $14.22 range, while the stock trades near $13.83. Alphatec reported preliminary Q4 and full-yea…
SoFi Technologies general counsel Robert S. Lavet bought 5,000 shares of the company's stock on February 6, 2026, according to a Form 4 filing. The purchase was executed at $21.044 per share for a total of $105,220. Following the transaction, Lavet indirectly holds 17,172 shares through the Robert S. Lavet Trust. The insider move comes after SoFi r…
Cynthia L. Tregillis, Western Digital's Chief Legal Officer and Corporate Secretary, sold 6,780 shares of the company on February 6, 2026, at $270.49 per share, for roughly $1.83 million. The transaction leaves her with 136,538 directly held shares. The sale comes as Western Digital rolled out a 40TB UltraSMR ePMR drive and outlined roadmaps to 60T…
Matthew E. Massengill, a director at Western Digital Corp, sold 39,513 shares on February 5, 2026, in transactions executed under a pre-arranged Rule 10b5-1 plan, totaling $9,616,465. The company has concurrently been the subject of multiple analyst target changes and reiterated growth expectations tied to AI-driven data expansion and new hard driv…
Syndax Pharmaceuticals CEO Michael A. Metzger sold 7,412 shares on Feb. 6, 2026 for $20.62 apiece, generating $152,835 in proceeds. The company’s shares have risen 63% over six months and trade near $21.01. Recent corporate disclosures show significant stock grants and option awards to Metzger on Feb. 4, while clinical data and analyst buy ratings …
Director Blake Borgeson sold 220,000 shares of Recursion Pharmaceuticals on February 3, 2026, for $4.20 per share, a transaction valued at $924,000 executed under a Rule 10b5-1 trading plan. The sale occurred while the stock has declined 5% over the past week and 45% year-over-year, trading at $3.96 — below Borgeson’s sale price. Post-sale, Borgeso…
Recursion Pharmaceuticals director Christopher Gibson executed a planned sale of Class A shares that generated $164,800 and completed a Class B-to-A conversion, followed days later by a stock-based acquisition to cover tax obligations. The transactions occur against a backdrop of a 45% year-over-year share decline, weak company financial metrics, a…
Syndax Pharmaceuticals Chief Financial Officer Keith A. Goldan completed a mix of share transactions in late January and early February 2026, including a sale of 2,082 shares for roughly $42,930, several zero-priced transfers, and an option award. The company also disclosed encouraging clinical results for its menin inhibitor Revuforj presented at …
